Diprivan and Haemangioma - a phase IV clinical study of FDA data

Summary:

Haemangioma is reported as a side effect among people who take Diprivan (propofol), especially for people who are female, 50-59 old, also take Zofran, and have Osteoporosis.

The phase IV clinical study analyzes which people have Haemangioma when taking Diprivan. It is created by eHealthMe based on reports of 6,477 people who have side effects when taking Diprivan from the FDA, and is updated regularly.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

What is Haemangioma?

Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs) is found to be associated with 563 drugs and 833 conditions by eHealthMe. Check the latest studies of Haemangioma.

On Aug, 05, 2026

6,477 people reported to have side effects when taking Diprivan.
Among them, 29 people (0.45%) have Haemangioma.

Among these 29 people:

What is the gender of people who have Haemangioma when taking Diprivan? *

female: 100 %
male: 0.0 %

What is the age of people who have Haemangioma when taking Diprivan? *

What are other drugs people take besides Diprivan? *

What are other side effects people have besides Haemangioma? *

Swelling: 28 people, 96.55%
Pneumonia: 28 people, 96.55%
Pain: 28 people, 96.55%
Appendicitis (inflammation of the appendix): 27 people, 93.10%
Generalised Oedema (swelling all over the body): 27 people, 93.10%
Gingival Pain (gum pain): 27 people, 93.10%
Gingivitis (inflammation of gums): 27 people, 93.10%
Gums - Swollen: 27 people, 93.10%
Humerus Fracture (injury to the upper arm bone): 27 people, 93.10%
Joint Dislocation (a joint position is changed from normal position): 27 people, 93.10%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 27 people, 93.10%
Osteoporosis (bones weak and more likely to break): 27 people, 93.10%
Thrombocytopenia (decrease of platelets in blood): 11 people, 37.93%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Diprivan and have Haemangioma?

- Check whether Haemangioma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diprivan:

Diprivan (6,496 reports)

Haemangioma treatments and more:

Haemangioma (4,731 reports)

Browse all side effects of Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemangioma:

Haemangioma (563 drugs)

Browse all the conditions that are associated with Haemangioma:

Haemangioma (833 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on propofol (the active ingredients of Diprivan) and Diprivan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.